Subscribe To
OM / Supercharged Returns: 2 Growth Stocks That Could Turn $1,000 Into $10,000
OM News
By Zacks Investment Research
November 2, 2023
After Plunging -62.36% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical, Inc. (OM)
Outset Medical, Inc. (OM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined w more_horizontal
By Zacks Investment Research
October 17, 2023
Down -68.16% in 4 Weeks, Here's Why You Should You Buy the Dip in Outset Medical, Inc. (OM)
The heavy selling pressure might have exhausted for Outset Medical, Inc. (OM) as it is technically in oversold territory now. In addition to this tech more_horizontal
By Proactive Investors
October 13, 2023
Outset Medical analysts slash price objective after multiple missteps
Outset Medical Inc stock was downgraded by BofA Securities analysts to ‘Underperform' from ‘Buy', and its price objective was cut to $3 per share more_horizontal
By Proactive Investors
October 13, 2023
Outset Medical stock plunges on revenue hit from FDA warning letter
Outset Medical Inc shares sank as much as 40% in pre-market trading on Friday after the medical technology company reported lower-than-expected prelim more_horizontal
By Seeking Alpha
October 6, 2023
Outset Medical Faces Regulatory Delays Amid Heavy Cash Burn (Rating Downgrade)
Outset Medical, Inc. is commercializing a new hemodialysis machine for acute care and home settings. The company has reduced guidance due to pulling i more_horizontal
By Zacks Investment Research
August 2, 2023
Outset Medical, Inc. (OM) Reports Q2 Loss, Tops Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $0.73. This compares to l more_horizontal
By Seeking Alpha
July 21, 2023
Outset Medical: Expansive TAM, Yet Profitability Remains Distant
Outset Medical Inc's share price has risen by over 11% over the past year, but the company lacks a positive bottom line, making it a risky investment. more_horizontal
By The Motley Fool
July 10, 2023
Why Shares of Outset Medical Are Down Monday
Outset said it received a Warning Letter from the FDA last week. The letter raised two new concerns regarding the company's dialysis products. more_horizontal